Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

R u kidding me? 114 out of 541

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
ScienceOC Member Profile
 
Followed By 1
Posts 52
Boards Moderated 0
Alias Born 05/06/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 5:01:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/2/2020 8:01:17 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 5/15/2020 8:47:08 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2020 6:00:59 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/30/2020 5:28:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 5:29:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2020 5:03:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2020 5:08:55 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 4/22/2020 7:35:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2020 5:38:33 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2020 5:16:18 PM
The Next Hot Sector is Upon us and You Will Never Guess What It is InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/9/2020 4:45:19 PM
Other Filing Edgar (US Regulatory) - 4/9/2020 10:24:51 AM
Other Filing Edgar (US Regulatory) - 4/9/2020 10:24:21 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 4/7/2020 10:48:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 5:06:53 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/30/2020 5:25:25 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/30/2020 4:08:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2020 4:31:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/18/2020 3:30:44 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/18/2020 3:06:56 PM
WBSI Alert - $0.80 PPS with Potential to $10.00 on New DriveSafety APP Launch InvestorsHub NewsWire - 2/26/2020 10:50:36 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 5:09:13 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 2/14/2020 6:08:12 AM
ScienceOC   Saturday, 05/23/20 06:55:12 PM
Re: None
Post # of 82066 
R u kidding me? 114 out of 541 patient taking Remdesivir reported SERIOUS adverse event!

No wonder why death rate is so high in US.

This is from an article in NEJM:
Remdesivir for the Treatment of Covid-19 — Preliminary Report

This is double blinded study (Remdesivir vs placebo)
Summary:
Serious adverse events were reported for 114 of the 541 patients in the remdesivir group who underwent randomization (21.1%) and 141 of the 522 patients in the placebo group who underwent randomization (27.0%).
Mortality was numerically lower in the remdesivir group than in the placebo group, but the difference was NOT significant (hazard ratio for death, 0.70; 95% CI, 0.47 to 1.04; 1059 patients).

Forty-nine patients had remdesivir treatment discontinued before day 10 because of an adverse event or a serious adverse event other than death (36 patients) or because the patient withdrew consent (13).

One of their conclusions:
However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient.

This was funded by (Dr. Fauci's dept NIAID):
The trial was sponsored and primarily funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist